awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33410213-9FAC1A4E-5D28-4B8F-93E4-22B85D8909CC
Q33410213-9FAC1A4E-5D28-4B8F-93E4-22B85D8909CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410213-9FAC1A4E-5D28-4B8F-93E4-22B85D8909CC
Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.
P2860
Q33410213-9FAC1A4E-5D28-4B8F-93E4-22B85D8909CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410213-9FAC1A4E-5D28-4B8F-93E4-22B85D8909CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53974e0ac070b0e36118e30408d97f31b6a79fc9
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.